Your primary contact persons

Priv.-Doz. Dr. med. habil. K.-U. Seiler

CEO of AKP since the company’s formation in 1996. After his long-standing university career in Kiel, Germany he joined the pharmaceutical industry in 1985 as Head of Clinical Research for Janssen (Germany), and later Head of Cardiovascular Clinical Research for Parke-Davis. Dr. Seiler is a recognized specialist in clinical pharmacology and internal medicine.

Hilde Huber, Dipl.-Biologist

Graduate degree in biology, ECPM diploma in Pharmaceutical Medicine. Extensive experience in clinical trial monitoring and project management for AKP, Parke-Davis and Gödecke.

She joined AKP in 1997, becoming Director Of Clinical Operations in 2001 and since 2007 she has been CEO. Ms. Huber is in charge of the monitoring sector, project management, quality assurance and internal training.